Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure

American Heart Journal

Volumn 146, Issue 4, 2003, Pages 736-740

  Baker, David W ^a   Bahler, Robert C ^b   Finkelhor, Robert S ^b   Lauer, Michael S ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ANAMNESIS; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; GENERAL PRACTICE; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; RISK FACTOR; SCREENING; SYMPTOM;

EID: 0142088787     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00396-X     Document Type: Article

References (23)

1. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-33.
2. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
3. McMurray JV, McDonagh TA, Davie AP, et al. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 1998;19:842-6.
4. Mosterd A, de Bruijne MC, Hoes AW, et al. Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (the Rotterdam Study). Am J Cardiol 1997;79:103-4.
5. Davies MK, Hobbs FDR, Davis RC, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England study: a population based study. Lancet 2001;358:439-44.
6. Vasan RS, Larson MG, Benjamin EJ, et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997;336:1350-5.
7. Baker DW. Prevention of heart failure. J Card Fail 2002;8:333-46.
8. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
9. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:6A-13A.
10. Kannel WB, Castelli WP, McNamara PM, et al. Role of blood pressure in the development of congestive heart failure: the Framingham study. N Engl J Med 1972;287:781-7.
11. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J 1987;8(Suppl F):23-6.
12. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-7.
13. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code: Manual Of Electrocardiographic Findings. London: John Wright; 1982.
14. Murphy ML, Thenabadu PN, de Soyza N, et al. Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy. Am J Cardiol 1984;53;1140-7.
15. The sixth report of the Joint National Committee on Prevention, Detection, and Evaluation of High Blood Pressure. Arch Intern Med 1997;157:2413-45.
16. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology. 2nd ed. Baltimore: Williams & Wilkins; 1988. p. 159-60.
17. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mamograms and clinical breast examinations. N Engl J Med 1998;338:1089-96.
18. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
19. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left-ventricular ejection fractions. N Engl J Med 1992;327:685-91.
20. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial: the SAVE Investigators. N Engl J Med 1992;327:669-77.
21. Abraham WT. Beta-blockers: the new standard of therapy for mild heart failure. Arch Intern Med 2000;160:1237-47.
22. Watanabe J, Thamilarasan M, Blackstone EH, et al. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation 2001;104:1911-6.
23. Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 2002;288:1252-9.